Preface [Hot Topic:Anabolic Agents for the Treatment of Osteoporosis (Executive Editor: Naohisa Miyakoshi)]
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
i-i
Author(s):
Naohisa Miyakoshi
Osteoblast Differentiation and Control by Vitamin D and Vitamin D Metabolites
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2535-2555
Author(s):
M. Driel van, H. A.P. Pols and J.P. T.M. van Leeuwen
The Anabolic Effects of GH / IGF System on Bone
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2577-2592
Author(s):
Yuji Kasukawa, Naohisa Miyakoshi and Subburaman Mohan
Growth Factors and Bone Formation in Osteoporosis: Roles for Fibroblast Growth Factor and Transforming Growth Factor Beta
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2593-2603
Author(s):
Olivia Fromigué, Dominique Modrowski and Pierre J. Marie
Osteoporosis Requires Bone-Specific Statins
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2605-2613
Author(s):
Masao Koida, Ryo Fukuyama and Hiromichi Nakamuta
Exercise as an Anabolic Stimulus for Bone
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2629-2641
Author(s):
Charles H. Turner and Alexander G. Robling
Testosterone Action on the Sertoli Cell Membrane: A KIR6.x Channel Related Effect
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2649-2656
Author(s):
Wassermann G. F. and Loss E. S.
Mitotic and Gender Parallels in Alzheimer Disease: Therapeutic Opportunities
Journal:
Current Drug Targets
Volume:
5
Page:
559-563
Author(s):
X. Zhu, K. M. Webber, G. Casadesus, A. K. Raina, H. G. Lee, M. Marlatt, A. Hartzler, C. S. Atwood, R. Bowen, G. Perry and M. A. Smith
A New Alzheimers Disease Interventive Strategy: GLP-1
Journal:
Current Drug Targets
Volume:
5
Page:
565-571
Author(s):
Tracy Ann Perry and Nigel H. Greig
Evolutionary Plasticity of Vertebrate Hox Genes
Journal:
Current Genomics
Volume:
5
Page:
459-472
Author(s):
Thomas P. Powers and Chris T. Amemiya